Evidence map›Paper›PMID 39134006›Full record

ArticleCerebrovascular diseases extra2024

Clinical Features and Treatment Outcomes in Patients in Their Twenties with Ischemic Moyamoya Disease.

Yutaro Ono, Yosuke Akamatsu, Shizuka Araya, Ryouga Yamazaki, Shunrou Fujiwara, Kohei Chida, Masakazu Kobayashi, Takahiro Koji, Kazunori Terasaki, Kuniaki Ogasawara

Abstract readComparative Study
In one paragraph

Article in Cerebrovascular diseases extra, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yutaro OnoDepartment of Neurosurgery, School of Medicine, Iwate Medical University, Yahaba, Japan.
Yosuke AkamatsuDepartment of Neurosurgery, School of Medicine, Iwate Medical University, Yahaba, Japan.
Shizuka ArayaDepartment of Neurosurgery, School of Medicine, Iwate Medical University, Yahaba, Japan.
Ryouga YamazakiDepartment of Neurosurgery, School of Medicine, Iwate Medical University, Yahaba, Japan.
Shunrou FujiwaraDivision of Molecular and Cellular Pharmacology, Department of Pathophysiology and Pharmacology, School of Pharmaceutical Science, Iwate Medical University, Yahaba, Japan.
Kohei ChidaDepartment of Neurosurgery, School of Medicine, Iwate Medical University, Yahaba, Japan.
Masakazu KobayashiDepartment of Neurosurgery, School of Medicine, Iwate Medical University, Yahaba, Japan.
Takahiro KojiDepartment of Neurosurgery, School of Medicine, Iwate Medical University, Yahaba, Japan.
Kazunori TerasakiInstitute for Biomedical Sciences, Iwate Medical University, Yahaba, Japan.
Kuniaki OgasawaraDepartment of Neurosurgery, School of Medicine, Iwate Medical University, Yahaba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRevascularization surgery is recommended for all pediatric patients with moyamoya disease (MMD) with ischemic symptoms because the brains of such patients are still developing. By contrast, no clear guidelines for selective revascularization surgery in adult patients (30 years or more) with ischemic presentation have been established. Regarding the age of initial onset of ischemic MMD, patients in their 20s are at the bottom of the distribution and this age group may share features with both adult and pediatric patients. The present prospective study aimed to clarify the clinical features and treatment outcomes of patients in their 20s (younger patients) with ischemic MMD compared with patients aged 30-60 years (older patients).

methodsWhile patients with misery perfusion in the symptomatic cerebral hemisphere on 15O-positron emission tomography underwent combined surgery including direct and indirect revascularizations in the first study period and indirect revascularization alone in the second study period, patients without misery perfusion in that hemisphere received pharmacotherapy alone through the two study periods. Cerebral angiography via arterial catheterization and neuropsychological testing were performed before and after surgery.

resultsDuring 12 years, 12 younger patients were included and comprised 6% of all adult patients (194 patients). The incidence of misery perfusion in the affected hemisphere was significantly higher in younger (12/12 [100%]) than in older patients (57/182 [31%]) (p < 0.0001). No difference in the incidence of cerebral hyperperfusion syndrome and postoperatively declined cognition was seen between younger (2/5 [40%] and 2/5 [40%], respectively) and older (11/36 [31%] and 15/36 [42%], respectively) cerebral hemispheres undergoing combined revascularization surgery. No difference in the incidence of postoperatively formed collateral flows feeding more than one-third of the middle cerebral artery cortical territory on angiograms and postoperatively improved cognition was seen between younger (9/10 [90%] and 6/10 [60%], respectively) and older (18/22 [83%] and 14/22 [64%], respectively) cerebral hemispheres undergoing indirect revascularization surgery alone.

conclusionPatients in their 20s with ischemic MMD always exhibit misery perfusion in the affected hemisphere, unlike older patients, and sometimes develop cerebral hyperperfusion syndrome after combined revascularization surgery, leading to cognitive decline, similar to older patients. Moreover, indirect revascularization surgery alone forms sufficient collateral circulation and restores cognitive function in patients in their 20s, similar to older patients.

Indexed as

Cerebral RevascularizationCerebrovascular CirculationMoyamoya DiseaseAdultAge FactorsBrain IschemiaCerebral AngiographyCognitionFemaleHumansMaleMiddle AgedPerfusion ImagingPositron-Emission TomographyProspective StudiesRisk FactorsIschemiaMisery perfusionMoyamoya diseaseRevascularizationTwenties

Identifiers

PMID39134006
PMCPMC11521479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.